6:00P - 7:00P
What's All the "GABA" About? Pregabalin and Gabapentin Abuse
Faculty Courtney M. Kominek
The gabapentinoids are a popular class of medications among prescribers for use in chronic pain and various other neurological conditions. In fact, prescription rates for both gabapentin and pregabalin have increased in the United States and other countries in recent years. However, these medications have a street value to a newer niche of users, including patients taking them at megadoses to enhance the effects of other psychotropic drugs, and other patients taking them to manage or mitigate opioid withdrawal symptoms and possibly even opioid cravings. While pregabalin is already classified as a controlled substance, gabapentin does not yet carry this classification. In response to rising abuse, various states and regulatory bodies are considering changes to enhance patient safety and protect the provider’s license. Learn what changes you should make to your practice, if any, in light of the growing abuse of gabapentinoids and how to identify patients potentially abusing them.
Rx hours 0.0
7:00P - 7:45P
Topical Analgesics as 1st Line Agents
Sponsored by Hisamitsu America, Inc.
Faculty Jeffrey A. Gudin
A presentation by Jeffrey Gudin, MD reviewing the data that makes the clinical case for topical analgesics as 1st Line agents and provides an overview of the Salonpas line of topical analgesics with emphasis on the clinically proven treatments.
7:45P - 8:45P
Triple Threat or Epiphany? The Need for a Bio-Psycho-Social Approach to Pain Management
Faculty Kevin L. Zacharoff
Over the past 20 years, much has happened in the pain care environment, ranging from identifying the undertreatment of pain and encouraging adequate treatment to discouraging prescribing opioids too liberally for that purpose. We have heard some experts debate approaching pain treatment from a tailored, mechanistic perspective vs treating the “person” from a humanistic perspective. Unfortunately, even when there are discussions about nonpharmacologic attempts to treat pain, such as behavioral approaches, they are often presented in a form that makes them seem siloed and unharmonious with a biomedical approach. This presentation will discuss the rationale of biomedical and biopsychosocial models of pain treatment, their roles in treating pain, and propose a way to harness them in a synergistic, nonreductionistic approach that considers patient context, maximizes safety, and improves patient engagement, ultimately trying to maintain and/or restore function and quality of life.
Rx hours 0.0
The program guide will be available before the webinar.
CE/CME and Accreditation
This activity is provided by Global Education Group.
The educational design of this activity addresses the needs of frontline clinicians: physicians, nurses, nurse practitioners, physician assistants, and pharmacists involved in managing acute and chronic pain.
Statement of Need/Program Overview
Whether you're in a hospital or office-based practice, chronic pain patients are everywhere--and YOU are absorbing the burden of their care.
A just released report by the National Institutes of Health outlines positive steps that practitioners can take in response to the burgeoning problem of prescription medication abuse and to provide more effective pain management care to their patients. Key among these is access to pain education, and by participating in a PAINWeek PREMIERE Conference, you'll improve your skills in medication risk evaluation and mitigation, in pain assessment and diagnosis, and in the delivery of individualized multimodal treatment.
The PREMIERE agenda is purposely constructed for the busy clinician, delivering a full day of relevant, practical information, together with the opportunity for interaction and exchange with faculty and fellow attendees.
Pain Management for the Main Street Practitioner has been created to streamline the clutter of information on assessment, evolving guidelines, risk management, and changing reimbursement scenarios. Join us for a day of clinical and practice management CE/CME designed expressly for frontline clinicians. Participants can receive 2.0 AMA PRA Category 1 Credits™ as they expand their capabilities in the assessment, diagnosis, and management of chronic pain conditions.
- Review the proposed mechanisms of action for gabapentin and pregabalin
- Describe the rationale of biomedical and biopsychosocial pain treatment models
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
* This CE/CME activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 2.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).
Nursing Credit Designation
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 2.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2.0 hours of Category 1 credit for completing this program.
Pharmacy Credit Designation
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge-based activity. UANs are in the agenda.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must attend the courses. Web link to credit application and evaluation form will be emailed to participants the following week. Once completed, participants will be able to immediately download/print their certificates. Pharmacy learners will have their credits uploaded directly to NABP within 60 days of completion.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (physical, dietary, etc). Please contact Patrick Kelly prior to the live event at (973) 415-5109.
For information about the accreditation of this program, please contact Global at (303) 395-1782 or email@example.com.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ashley Marostica, RN, MSN—Nothing to disclose
Kristin Delisi, NP—Nothing to disclose
Andrea Funk—Nothing to disclose
Lindsay Borvansky—Nothing to disclose
Liddy Knight—Nothing to disclose